Calculating the individual probability of successful ocriplasmin treatment in eyes with VMT syndrome: a multivariable prediction model from the EXPORT study.

Christoph PaulChristine HeunHans-Helge MüllerHans HoeraufNicolas FeltgenJoachim WachtlinHakan KaymakStefan MennelMichael Janusz KossSascha FauserMathias M MaierRicarda G SchumannSimone MuellerPetrus ChangSteffen Schmitz-ValckenbergSara KazerounianPeter SzurmanAlbrecht LommatzschThomas Bertelmann

Published in: The British journal of ophthalmology (2017)

Known predictive factors for VMT resolution after ocriplasmin IVI were confirmed in our study. We were able to combine them into a formula, ultimately allowing the calculation of an individual probability of treatment success with ocriplasmin in patients with VMT syndrome without FTHM.

Keyphrases

case report
optical coherence tomography
combination therapy
single molecule
preterm infants
smoking cessation
replacement therapy
low birth weight